Can I read Secukinumab vs Ustekinumab in Psoriasis on EtoBox?
Secukinumab vs Ustekinumab in Psoriasis by Andi Marsali is a document available to read on EtoBox.
What is Secukinumab vs Ustekinumab in Psoriasis about?
The CLEAR study demonstrates that secukinumab is superior to ustekinumab in achieving significant skin clearance in patients with moderate to severe plaque psoriasis, with a PASI 90 response rate of 79.0% compared to 57.6% for ustekinumab at week 16. Additionally, secukinumab showed a comparable safety profile to ustekinumab. These findings support secukinumab as a more effective treatment option for improving health-related quality of life in psoriasis patients.
- Author
- Andi Marsali
- Language
- EN